Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).

NCT05201131 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-01-21

No results posted yet for this study

Summary

To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.

Conditions

  • Urologic Diseases

Interventions

PROCEDURE

Rezum

Rezum

Sponsors & Collaborators

  • Can-Am HIFU Inc.

    lead OTHER

Principal Investigators

  • Dean Elterman · University Health Network, Toronto

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-07
Primary Completion
2023-12-31
Completion
2026-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201131 on ClinicalTrials.gov